Physician profile
Jacob R Zide
NPI 1114127164
$18,945.54
in general payments reported to CMS, 2019-2025
16 companies · $734 in 2025
The $734 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,120 · 2020: $2,241 · 2021: $650 · 2022: $3,553 · 2023: $3,651 · 2024: $5,996 · 2025: $734.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,368 · Travel and Lodging: $2,930 · Food and Beverage: $1,788 · Education: $296.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,367.50 |
| Travel and Lodging | $2,929.75 |
| Food and Beverage | $1,788.07 |
| Education | $296.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $12,066.56 | 2019-2024 | Truelok, Truelok System, Tl-Hex Truelok Hexapod System |
| Vilex LLC | $3,048.38 | 2023 | |
| Stryker Corporation | $2,466.81 | 2020-2025 | Prophecy, Infinity, Augment Injectable |
| Pylant Medical | $570.43 | 2019-2025 | |
| Smith+Nephew, INC. | $287.11 | 2019-2021 | |
| Restor3d, INC. | $207.43 | 2024 | |
| Djo, LLC | $76.69 | 2021 | |
| Wright Medical Technology, INC. | $67.12 | 2019-2020 | |
| Horizon Therapeutics Plc | $32.69 | 2019 | |
| Fusion Orthopedics USA, LLC | $25.66 | 2024 | |
| Zimmer Biomet Holdings, INC. | $21.91 | 2024 | Gps III Platelet Concentration System |
| Kerecis Limited | $18.04 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Depuy Synthes Sales INC. | $15.66 | 2022 | |
| Merck Sharp & Dohme LLC | $14.71 | 2022 | |
| Acelrx Pharmaceuticals, INC. | $13.36 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $12.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Zide listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.